NEXGEL, INC. Business Acquisition, Pro Forma Net Income (Loss)
NEXGEL, INC. (NXGL) reported Business Acquisition, Pro Forma Net Income (Loss) of -$4.31 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2022-03-21
- NEXGEL, INC. business acquisition, pro forma net income (loss) for the quarter ending 2021-12-31 was -$1.64K.
- NEXGEL, INC. business acquisition, pro forma net income (loss) for the quarter ending 2021-09-30 was -$1.14K, a 100.11% decline year-over-year.
- NEXGEL, INC. business acquisition, pro forma net income (loss) for the quarter ending 2021-06-30 was -$874.00.
- NEXGEL, INC. business acquisition, pro forma net income (loss) for the quarter ending 2021-03-31 was -$655.00.
- NEXGEL, INC. business acquisition, pro forma net income (loss) for fiscal 2021 was -$4.31K.
- NEXGEL, INC. business acquisition, pro forma net income (loss) for fiscal 2020 was -$2.25K.
- NEXGEL, INC. business acquisition, pro forma net income (loss) for fiscal 2019 was -$1.96K.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$1.64K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$2.78K derived: sum of 2 quarters · filed 2022-03-21 | -$3.65K derived: sum of 3 quarters · filed 2022-03-21 | -$4.31K 10-K · filed 2022-03-21 | |
| 2021-09-30 | -$1.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$2.02K derived: sum of 2 quarters · filed 2021-11-10 | -$2.67K 10-Q · filed 2021-11-10 | -$3.39K derived: sum of 4 quarters · filed 2022-03-21 | |
| 2021-06-30 | -$874.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$1.53K 10-Q · filed 2021-08-16 | -$2.25K derived: sum of 3 quarters · filed 2022-03-21 | $1.03M derived: sum of 4 quarters · filed 2022-03-21 | |
| 2021-03-31 | -$655.00 10-Q · filed 2021-05-17 | -$1.37K derived: sum of 2 quarters · filed 2022-03-21 | $1.03M derived: sum of 3 quarters · filed 2022-03-21 | -$1.88K derived: sum of 4 quarters · filed 2022-03-21 | |
| 2020-12-31 | -$719.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $1.03M derived: sum of 2 quarters · filed 2022-03-21 | -$1.23K derived: sum of 3 quarters · filed 2022-03-21 | -$2.25K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$506.00 derived: sum of 2 quarters · filed 2021-11-10 | -$1.53K 10-Q · filed 2021-11-10 | -$1.90K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$1.03M 10-Q · filed 2020-08-14 | -$1.03M derived: sum of 3 quarters · filed 2021-08-16 | $650.04K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$1.03K 10-Q · filed 2021-08-16 | -$500.00 10-Q · filed 2021-05-17 | -$1.39K derived: sum of 2 quarters · filed 2021-08-16 | $1.68M derived: sum of 3 quarters · filed 2021-08-16 | |
| 2019-12-31 | -$362.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.68M derived: sum of 2 quarters · filed 2021-03-31 | -$1.96K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$1.60K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | -$1.68M 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |